2022 Drug Trend Report
Delivering
Double-Digit Savings
In 2022, new Navitus clients realized a 12% reduction in cost compared to the previous year with a different PBM.
Over the last five years, new Navitus commercial clients have saved between 12% to 25% in their first year:
case study
Delivering $11 Million in Savings
Putnam serves the employees and retirees of the Putnam and Northern Westchester (New York) public schools as well as Boards of Cooperative Educational Services (BOCES). In 2018, Putnam transitioned their pharmacy benefits to Navitus.
Navitus has enabled Putnam to save $11 million over five years by:
-
Eliminating spread pricing
-
Transitioning specialty pharmacy benefits to Lumicera
-
Implementing a limited pharmacy network
-
Increasing rebates with 100% pass through to the client
Moving to Navitus as our PBM in 2018 was one of the best decisions we've made as a company and one we wish we had made sooner. They truly look out for their clients' best interests and these numbers and results speak for themselves. Plus, they have a top-tier Account Management team and fantastic Customer Service that makes moving to Navitus a no-brainer.
Bharat Mistry
Sr. Director of Health and Welfare Benefits — Putnam Northern Westchester Health Benefits Consortium
GET THE 2022 DRUG TREND EXECUTIVE SUMMARY
Download your free copy